MindWalk Holdings (HYFT) Assets Growth (3y) (2023 - 2026)

MindWalk Holdings (HYFT) Assets Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Apr 30, 2026 -35.27%
Jan 31, 2026 -35.29%
Oct 31, 2025 -32.91%
Jul 31, 2025 -21.86%
Apr 30, 2025 -24.97%
Jan 31, 2025 -10.41%
Oct 31, 2024 -2.92%
Jul 31, 2024 -6.19%
Apr 30, 2024 -5.95%
Jan 31, 2024 19.76%
Oct 31, 2023 19.04%
Apr 30, 2023 42.58%